STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
Since inception in June 2009, the Fund has returned a total of +349%, which translates to 30% annualised
The Rhenman Healthcare Equity L/S, which invests in listed companies primarily in pharmaceuticals, medical technology, biotechnology and services, was awarded Best Nordic Equity Focused Hedge Fund 2014 and Best Performing Nordic Hedge Fund 2014 at the Annual Nordic Hedge Awards 2014, which is held to commend fund excellence in the Nordic hedge fund industry.
”This is the most prestigious award in the Nordic hedge fund space, and we are especially happy to win the category Best Equity Focused Hedge Fund for the third consecutive year. The universe in 2014 consisted of 161 hedge funds in total so it’s consequently a very competitive market, and it’s therefore very gratifying that our experienced investment team fair so well”, said Carl Grevelius, Founding Partner and Head of Marketing.
“The recognition confirms the importance of our unique investment process which includes a close cooperation with a Scientific Advisory Board consisting of a number of respected Professors each with over 30 years’ experience. The healthcare sector constitutes more than 10% of the total global equity market capitalisation which gives the fund many interesting investment opportunities to choose from,” said Carl Grevelius.
Since inception in June 2009, the fund has returned +349% net of fees. The annual returns of 2013 and 2014 were +55% and +43% respectively.
“We have initiated a soft-close procedure and expect to soft close the fund in October 2015. Existing shareholders can top-up and redeem on a monthly basis until fund AUM reaches EUR 1bn. Thereafter no additional investments will be allowed. Currently AUM stands at EUR 530m”, said Grevelius.
About Rhenman & Partners
Rhenman & Partners Asset Management is a Stockholm-based Fund Manager focusing on the healthcare sector. The company's assets under management amount to over EUR 530m. Rhenman & Partners was founded in 2008 by a trio with extensive experience of the asset management sector, as well as an unrivalled track record in the healthcare sector. Henrik Rhenman has over 20 years experience of managing successful healthcare funds.
The Rhenman Healthcare Equity L/S fund is unique in that it is supported by a Scientific Advisory Board composed of eminent professors, each with over 30 years in their field. The Group has access to a wide network of scientists and experts at several recognized institutions worldwide, including the Karolinska Institute.
The fund has a long term investment horizon and a diversified portfolio of around 60-80 core positions. Whilst trading around positions the fund remains diversified across subsectors, company size and geographies to lower volatility.
For more information, please visit www.rhepa.com
Rhenman Healthcare Equity L/S – Performance (EUR, Net of fees) –
Outstanding performance in a complex market.
|Since inception||+ 349%|
|YTD 2014 (March)||+ 27%|
This information was brought to you by Cision http://news.cision.com